Literature DB >> 16177000

Myocardial stiffness, cardiac remodeling, and diastolic dysfunction in calcification-prone fetuin-A-deficient mice.

Marc W Merx1, Cora Schäfer, Ralf Westenfeld, Vincent Brandenburg, Sylvia Hidajat, Christian Weber, Markus Ketteler, Willi Jahnen-Dechent.   

Abstract

Accelerated atherosclerosis in dialysis patients is characterized by severe vascular calcification, and the magnitude of vascular calcification is associated with increased cardiovascular mortality. Calcification-dependent arterial stiffness is considered to be a major determinant of cardiac failure in uremia. Fetuin-A/alpha(2)-Heremans-Schmid glycoprotein is an abundant serum protein with powerful calcification inhibitory properties. Fetuin-A deficiency was recently linked to cardiovascular mortality in dialysis patients. Fetuin-A knockout (fetuin-KO) mice spontaneously develop widespread soft tissue calcification, including significant myocardial calcification, whereas larger arteries are spared. Therefore, this investigation offers the unique opportunity to study the functional role of isolated myocardial calcification independent of arterial stiffness by assessing the hemodynamics of fetuin-KO mice. Cardiac output in fetuin-KO mice was lower than in wild-type mice (fetuin-KO 1.81 +/- 0.18 versus WT 2.45 +/- 0.29 ml/min per g; P < 0.005), and fetuin-KO mice were refractory to dobutamine stimulation. Left ventricular relaxation was significantly impaired in fetuin-KO hearts with the relaxation index reduced by 23% (P < 0.005). After ischemia, fetuin-KO hearts displayed a continuous decline in left ventricular developed pressure after the initial phase of reperfusion, resulting in 77 +/- 15% of preischemic left ventricular developed pressure (P < 0.05 versus wild-type). In fetuin-KO mice, dystrophic cardiac calcification, with myocardial calcium contents increased 60-fold, was associated with profound induction of profibrotic TGF-beta and downstream collagen and fibronectin mRNA synthesis. In conclusion, independent of arterial stiffness, calcification-associated "myocardial stiffness" characterized by cardiac fibrosis, diastolic dysfunction, impaired tolerance to ischemia, and catecholamine resistance thus may constitute an underestimated cardiovascular risk factor that contributes to cardiac failure in calcification-prone states.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16177000     DOI: 10.1681/ASN.2005040365

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  29 in total

Review 1.  Cardiorenal Syndrome and the Role of the Bone-Mineral Axis and Anemia.

Authors:  David M Charytan; Steven Fishbane; Jolanta Malyszko; Peter A McCullough; David Goldsmith
Journal:  Am J Kidney Dis       Date:  2015-02-26       Impact factor: 8.860

Review 2.  Pathogenesis of vascular calcification in dialysis patients.

Authors:  Markus Ketteler; Ralf Westenfeld; Georg Schlieper; Vincent Brandenburg
Journal:  Clin Exp Nephrol       Date:  2005-12       Impact factor: 2.801

3.  Usefulness of serum fetuin-A level as a marker of erectile dysfunction.

Authors:  W Kandeel; W El-Shaer; A Sebaey; A A Abou-Taleb; A Fathy; B Elmohamady; A I Mansour
Journal:  Int J Impot Res       Date:  2017-04-20       Impact factor: 2.896

4.  Gas6 protein: its role in cardiovascular calcification.

Authors:  Nadine Kaesler; Svenja Immendorf; Chun Ouyang; Marjolein Herfs; Nadja Drummen; Peter Carmeliet; Cees Vermeer; Jürgen Floege; Thilo Krüger; Georg Schlieper
Journal:  BMC Nephrol       Date:  2016-05-26       Impact factor: 2.388

Review 5.  Calcium as a cardiovascular toxin in CKD-MBD.

Authors:  Sharon M Moe
Journal:  Bone       Date:  2016-08-27       Impact factor: 4.398

6.  Associations of fetuin-A levels with vascular disease in type 2 diabetes patients with early diabetic nephropathy.

Authors:  Marcel Roos; Dimitrios Oikonomou; Maximilian von Eynatten; Peter B Luppa; Uwe Heemann; Jens Lutz; Marcus Baumann; Peter P Nawroth; Angelika Bierhaus; Per M Humpert
Journal:  Cardiovasc Diabetol       Date:  2010-09-07       Impact factor: 9.951

Review 7.  Effect of aging on cellular mechanotransduction.

Authors:  Miaozong Wu; Jacqueline Fannin; Kevin M Rice; Bin Wang; Eric R Blough
Journal:  Ageing Res Rev       Date:  2009-11-20       Impact factor: 10.895

8.  Meta-analysis and profiling of cardiac expression modules.

Authors:  Uri David Akavia; Dafna Benayahu
Journal:  Physiol Genomics       Date:  2008-09-09       Impact factor: 3.107

9.  Fetuin-A protects against atherosclerotic calcification in CKD.

Authors:  Ralf Westenfeld; Cora Schäfer; Thilo Krüger; Christian Haarmann; Leon J Schurgers; Chris Reutelingsperger; Ognen Ivanovski; Tilman Drueke; Ziad A Massy; Markus Ketteler; Jürgen Floege; Willi Jahnen-Dechent
Journal:  J Am Soc Nephrol       Date:  2009-04-23       Impact factor: 10.121

10.  Association of lower plasma fetuin-a levels with peripheral arterial disease in type 2 diabetes.

Authors:  Luis H Eraso; Naeema Ginwala; Atif N Qasim; Nehal N Mehta; Rachel Dlugash; Shiv Kapoor; Stanley Schwartz; Mark Schutta; Nayyar Iqbal; Emile R Mohler; Muredach P Reilly
Journal:  Diabetes Care       Date:  2009-11-12       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.